|
1 General Examination Information |
|
|
1 | (4) |
|
|
|
1 | (1) |
|
|
|
1 | (1) |
|
|
|
2 | (1) |
|
|
|
3 | (2) |
|
|
|
5 | (20) |
|
|
|
5 | (8) |
|
Erikson's Psychosocial Stages of Development |
|
|
13 | (1) |
|
Piaget's Theory of Cognitive Development |
|
|
14 | (1) |
|
|
|
15 | (1) |
|
|
|
16 | (1) |
|
Family Dynamics and Environmental Influences |
|
|
17 | (1) |
|
|
|
18 | (4) |
|
|
|
22 | (3) |
|
3 Medication Administration, Over-The-Counter Analgesics, And Complementary Therapies |
|
|
25 | (6) |
|
Medication Administration |
|
|
25 | (1) |
|
Over-the-Counter Analgesics |
|
|
26 | (1) |
|
|
|
27 | (1) |
|
Complementary and Alternative Therapies |
|
|
28 | (2) |
|
|
|
30 | (1) |
|
|
|
31 | (28) |
|
Assessment and Management |
|
|
31 | (2) |
|
Attention Deficit Hyperactivity Disorder |
|
|
33 | (7) |
|
|
|
40 | (1) |
|
|
|
41 | (2) |
|
|
|
43 | (3) |
|
|
|
46 | (2) |
|
|
|
48 | (1) |
|
|
|
49 | (2) |
|
|
|
51 | (2) |
|
|
|
53 | (3) |
|
|
|
56 | (3) |
|
5 Eyes, Ears, Nose, And Throat |
|
|
59 | (14) |
|
|
|
59 | (1) |
|
|
|
59 | (1) |
|
|
|
59 | (1) |
|
|
|
60 | (2) |
|
|
|
62 | (1) |
|
|
|
62 | (1) |
|
|
|
63 | (1) |
|
|
|
64 | (1) |
|
|
|
65 | (1) |
|
|
|
65 | (1) |
|
|
|
65 | (1) |
|
|
|
66 | (1) |
|
|
|
67 | (1) |
|
|
|
67 | (1) |
|
|
|
67 | (1) |
|
|
|
68 | (1) |
|
Streptococcal Pharyngitis |
|
|
69 | (1) |
|
|
|
70 | (1) |
|
|
|
71 | (2) |
|
|
|
73 | (26) |
|
|
|
73 | (1) |
|
|
|
74 | (4) |
|
Atrioventricular Septal Defect |
|
|
78 | (1) |
|
|
|
79 | (2) |
|
Hypoplastic Left Heart Syndrome |
|
|
81 | (2) |
|
|
|
83 | (1) |
|
|
|
84 | (2) |
|
Ventricular Septal Defect |
|
|
86 | (2) |
|
Inflammatory Cardiovascular Conditions |
|
|
88 | (1) |
|
Endocarditis, Myocarditis, and Pericarditis |
|
|
88 | (1) |
|
|
|
89 | (2) |
|
|
|
91 | (1) |
|
|
|
92 | (1) |
|
|
|
92 | (1) |
|
|
|
92 | (2) |
|
|
|
94 | (1) |
|
|
|
95 | (4) |
|
|
|
99 | (16) |
|
Assessment and Management |
|
|
99 | (1) |
|
|
|
100 | (4) |
|
|
|
104 | (2) |
|
Carbon Monoxide Poisoning |
|
|
106 | (1) |
|
|
|
107 | (1) |
|
|
|
108 | (2) |
|
|
|
110 | (1) |
|
|
|
111 | (1) |
|
|
|
112 | (1) |
|
|
|
113 | (2) |
|
8 Gastrointestinal System |
|
|
115 | (22) |
|
|
|
115 | (4) |
|
|
|
119 | (3) |
|
Enteral Tube Placement and Maintenance 12C Failure to Thrive |
|
|
122 | (1) |
|
Fluid and Electrolyte Administration |
|
|
123 | (2) |
|
|
|
125 | (2) |
|
Gastroesophageal Reflux Disease |
|
|
127 | (1) |
|
|
|
128 | (1) |
|
Inflammatory Bowel Disease |
|
|
129 | (4) |
|
|
|
133 | (1) |
|
|
|
134 | (1) |
|
|
|
135 | (2) |
|
9 Genitourinary And Renal System |
|
|
137 | (10) |
|
Assessment and Management of Drains |
|
|
137 | (1) |
|
|
|
138 | (1) |
|
|
|
139 | (2) |
|
|
|
141 | (1) |
|
|
|
142 | (1) |
|
|
|
143 | (1) |
|
|
|
144 | (2) |
|
|
|
146 | (1) |
|
|
|
147 | (18) |
|
|
|
147 | (7) |
|
|
|
154 | (1) |
|
|
|
155 | (1) |
|
|
|
156 | (2) |
|
|
|
158 | (1) |
|
|
|
159 | (2) |
|
Syndrome of Inappropriate Antidiuretic Hormone Secretion |
|
|
161 | (1) |
|
|
|
162 | (3) |
|
11 Hematology And Oncology |
|
|
165 | (14) |
|
|
|
165 | (3) |
|
Blood Product Administration |
|
|
168 | (2) |
|
Immune Thrombocytopenic Purpura |
|
|
170 | (1) |
|
|
|
171 | (2) |
|
|
|
173 | (1) |
|
|
|
174 | (2) |
|
|
|
176 | (3) |
|
12 Musculoskeletal System |
|
|
179 | (8) |
|
Developmental Dysplasia of the Hip |
|
|
179 | (1) |
|
|
|
180 | (1) |
|
Juvenile Idiopathic Arthritis |
|
|
181 | (2) |
|
|
|
183 | (1) |
|
|
|
184 | (1) |
|
|
|
185 | (1) |
|
|
|
186 | (1) |
|
|
|
187 | (10) |
|
|
|
187 | (3) |
|
|
|
190 | (1) |
|
|
|
191 | (1) |
|
|
|
192 | (1) |
|
Tinea Infections (Ringworm) |
|
|
193 | (1) |
|
|
|
194 | (2) |
|
|
|
196 | (1) |
|
|
|
197 | (14) |
|
|
|
197 | (1) |
|
Fifth Disease (Erythema Infectiosum) |
|
|
197 | (1) |
|
Hand, Foot, and Mouth Disease |
|
|
198 | (1) |
|
|
|
199 | (2) |
|
|
|
201 | (2) |
|
|
|
203 | (1) |
|
|
|
204 | (1) |
|
|
|
205 | (2) |
|
|
|
207 | (1) |
|
|
|
208 | (3) |
|
15 Behavioral And Mental Health |
|
|
211 | (12) |
|
|
|
211 | (2) |
|
Bullying and Social Media Use |
|
|
213 | (1) |
|
|
|
214 | (1) |
|
|
|
215 | (1) |
|
Gender Identity and Sexual Orientation |
|
|
216 | (1) |
|
Neonatal Abstinence Syndrome |
|
|
217 | (1) |
|
|
|
218 | (2) |
|
|
|
220 | (1) |
|
|
|
221 | (2) |
|
|
|
223 | (10) |
|
|
|
223 | (1) |
|
|
|
224 | (1) |
|
Factitious Disorder in Another/Munchausen by Proxy |
|
|
225 | (1) |
|
|
|
226 | (2) |
|
|
|
228 | (2) |
|
|
|
230 | (1) |
|
|
|
230 | (3) |
|
17 Professional Responsibilities |
|
|
233 | (8) |
|
|
|
233 | (1) |
|
|
|
234 | (2) |
|
|
|
236 | (1) |
|
Palliative and End-of-Life Care |
|
|
237 | (1) |
|
Therapeutic Communication |
|
|
238 | (1) |
|
|
|
239 | (2) |
|
18 Practice Test Questions |
|
|
241 | (28) |
|
|
|
269 | (28) |
|
|
|
297 | (8) |
|
Appendix A Common Medications for Pediatrics |
|
|
305 | (8) |
|
Table A.1 Common Antibiotics and Antifungals for Pediatrics |
|
|
305 | (2) |
|
Table A.2 Common Pain and Sedation Medications for Pediatrics |
|
|
307 | (3) |
|
Table A.3 Common Steroids for Pediatrics |
|
|
310 | (3) |
| Index |
|
313 | |
Biežāk uzdotie jautājumi par e-grāmatām